Year: 2024
Type: article
Abstract: Over the last years, chimeric antigen receptor (CAR) T-cells have been approved for the treatment of relapsed or refractory large B-cell, mantle cell and follicular lymphoma (LBCL, MCL and FL, resp...
Institutions: Centre Hospitalier Universitaire de Rennes, Hospices Civils de Lyon, Centre Hospitalier Universitaire Henri-Mondor, Hôpitaux Universitaires Henri-Mondor, Centre National de la Recherche Scientifique, Centre Hospitalier Universitaire de Montpellier, Centre Hospitalier Universitaire de Poitiers
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4401535285